Flare Therapeutics Presents Part A Data from FX-909 Phase 1 Study at AACR-NCI-EORTC International Conference
October 24, 2025 12:00 ET | Source: Flare Therapeutics Inc. FX-909, the…
Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors
– QTX3034 monotherapy and the QTX3034-cetuximab combination demonstrated favorable safety profiles and…
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
October 24, 2025 11:39 ET | Source: PMV Pharmaceuticals, Inc. Data presented…
New Clinical Data Confirms Yomi Robotic System Enhances Efficiency in Dental Implant Surgery
October 23, 2025 13:48 ET | Source: Neocis MIAMI, Oct. 23, 2025…
Award-Winning Film An Inconvenient Study Sparks Global Debate on Vaccine Safety and Chronic Disease
AUSTIN, Texas, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The award-winning film An Inconvenient…
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
October 23, 2025 13:08 ET | Source: Progyny, Inc. NEW YORK, Oct.…
EdgeAI Wins Technology Frontier Award at 2025 Bincheng International Innovation & Entrepreneurship Competition
EdgeAI recognized for pioneering edge computing solutions at APAC Finals in Singapore.…
Switching from Lead-Acid to Lithium Is Easier Than You Think. LiTime’s One-Stop Upgrade Solutions Empower RV, Marine, and Other Users to Go Lithium with Ease
Shenzhen, China , Oct. 23, 2025 (GLOBE NEWSWIRE) -- Have you ever…
Sword Group: Acquisition of Full On Net, strengthening its expertise in data science and digital platforms
Sword Group is pleased to announce the acquisition of Full On Net,…
HearAdvisor Announces New Guide on the Best Hearing Aids and Earplugs of 2025 with Expert Choice Awards
October 22, 2025 17:59 ET | Source: HearAdvisor Rockford, Il, Oct. 22,…
